We are live on
!
Find out more
Fate Therapeutics
FATE
FATE
211 hedge funds and large institutions have $3.49B invested in Fate Therapeutics in 2020 Q3 according to their latest regulatory filings, with 29 funds opening new positions, 89 increasing their positions, 64 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
45% more first-time investments, than exits
New positions opened: 29 | Existing positions closed: 20
39% more repeat investments, than reductions
Existing positions increased: 89 | Existing positions reduced: 64
18% more capital invested
Capital invested by funds: $2.95B → $3.49B (+$544M)
14% more funds holding in top 10
Funds holding in top 10: 7 → 8 (+1)
4% more funds holding
Funds holding: 202 → 211 (+9)
1.36% less ownership
Funds ownership: 102.47% → 101.12% (-1.4%)
17% less call options, than puts
Call options by funds: $6.21M | Put options by funds: $7.44M
Holders
211
Holders Change
+9
Holders Change %
+4.46%
% of All Funds
4.26%
Holding in Top 10
8
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+14.29%
% of All Funds
0.16%
New
29
Increased
89
Reduced
64
Closed
20
Calls
$6.21M
Puts
$7.44M
Net Calls
-$1.23M
Net Calls Change
-$699K
Top Buyers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$41.1M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$37.5M |
| 3 |
Norges Bank
Oslo,
Norway
|
+$27.6M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$22.2M |
| 5 |
BlackRock
New York
|
+$16.3M |
Top Sellers
| 1 |
Citadel Advisors
Miami,
Florida
|
-$23.9M |
| 2 |
Millennium Management
New York
|
-$23.6M |
| 3 |
EC
EcoR1 Capital
San Francisco,
California
|
-$21.3M |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
-$17.2M |
| 5 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$13.1M |
